Example data

What the platform reports

Representative datasets from the DrugUptech screening platform. All traces are from live cells in 96-well plates on a standard fluorescence reader.

Multi-organism panels

Three Gram-negative pathogens on one plate

Rifampicin accumulation in Acinetobacter baumannii AYE, Pseudomonas aeruginosa PA01 and Klebsiella pneumoniae, followed over 30 minutes.

Rifampicin, 25 µM. Mean ± SD, n = 3 technical replicates. Direct-fluorescence mode. Time zero is the addition of compound.

Rifampicin accumulation, 25 micromolar, in AYE, PA01 and Klebsiella over 30 minutes

Why this matters for your chemistry

An accumulation deficit alone does not tell a medicinal chemist what to fix. Knowing that the loss is efflux points to pump-avoiding modifications; knowing it is permeability points to porin-friendly properties. The platform resolves the two in a single experiment and repeats cheaply as analogues arrive.

Beyond bacteria

The same measurement has been transferred to Candida, human cell lines (Caco-2, HEK293T), plant protoplasts and leaf discs from any plant species. Mammalian and plant experiments run over hours rather than minutes and are set up per project.

Compound scope

A broad detection window

The displacement-mode reporter was screened against a library of 55 clinically approved drugs spanning diverse chemotypes, with a limit of detection around 150 nM for responsive compounds. Detection mode is confirmed for every compound during project set-up, so you know before the uptake run whether it is measurable.

ColistinRifampicinHaloperidolClofazimineNevirapineBuspironeBupivacaineSolifenacinRotigotineCapivasertibFipronilVinpocetineand more

Have a dataset like this in mind for your compounds?

Send us a shortlist and the organisms or cells that matter. We will propose the panel, the benchmarks and the timeline.